Molina Healthcare, Inc. - 10-Q Summary (Q3 2009)
Business Context and Reporting Period
This filing covers the quarterly period ended September 30, 2009. Molina Healthcare, Inc. is a multi-state managed care organization serving low-income populations through government-sponsored programs (Medicaid, CHIP, and Medicare). Operations are conducted through 10 licensed health plans across California, Florida, Michigan, Missouri, Nevada, New Mexico, Ohio, Texas, Utah, and Washington. The company announced it will cease serving members in Nevada effective December 31, 2009.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2009 | Nine Months Ended Sep 30, 2009 |
|---|---|---|
| Premium Revenue | $914.8 million | $2,697.8 million |
| Total Revenue | $916.5 million | $2,705.1 million |
| Net Income | $8.6 million | $35.3 million |
| Diluted EPS | $0.33 | $1.36 |
| Medical Care Ratio | 86.7% | 86.5% |
| Operating Income | $16.3 million | $61.1 million |
| Cash and Cash Equivalents | $449.5 million | $449.5 million (Ending Balance) |
| Long-Term Debt | $157.7 million | $157.7 million (Carrying Amount) |
| Working Capital | $317.3 million | $317.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Premium revenue increased 16% year-over-year for the quarter and 18% for the nine-month period, driven primarily by membership growth (14% increase in total members to 1.41 million) and rate increases in specific states.
- Profitability Decline: Net income decreased 48% for the quarter ($8.6M vs. $16.5M) and 21% for the nine-month period ($35.3M vs. $44.8M). This was largely due to rising medical costs and losses in the California health plan.
- Medical Cost Trends: The medical care ratio increased to 86.7% (Q3) and 86.5% (YTD) compared to 84.6% and 84.9% in the prior year periods. Increased utilization, particularly in emergency rooms and outpatient services (partially attributed to the H1N1 flu), drove higher costs.
- California Performance: The California health plan reported a loss of approximately $4.8 million for the quarter and $15.2 million for the nine-month period, exerting downward pressure on consolidated results.
- Investment Income: Investment income dropped 64% for the quarter and 58% for the nine-month period due to lower interest rates.
Guidance, Outlook, and Risks
- California Turnaround: Management is implementing provider re-contracting and network restructuring. A combination of premium rate increases and tax relief effective October 1, 2009, is expected to improve California margins by approximately 4.9%.
- Utah Transition: The Utah health plan transitioned to a prepaid capitation contract on September 1, 2009, introducing new risk exposure regarding medical costs versus fixed revenue.
- H1N1 Flu Risk: The resurgence of the H1N1 flu in Q4 2009 creates uncertainty regarding utilization rates and medical costs for the remainder of the year.
- Rate Adequacy: Risks exist regarding state rate reductions (e.g., Washington, Michigan) not being fully commensurate with provider rate cuts or utilization patterns, potentially compressing margins.
- Tax Contingency: A $3.5 million tax benefit recorded in Q2 related to a settlement with the IRS regarding the Michigan Cape Health Plan acquisition is subject to review by the Joint Committee on Taxation. A reversal could materially impact results.
- Capital Resources: The company maintains a $200 million credit facility with no outstanding borrowings as of September 30, 2009. Management believes cash resources are sufficient for the next 12 months.
Investor Verification Checklist
- California Loss Trajectory: Verify if the October 1, 2009 rate increases and operational changes are sufficient to reverse the significant losses in the California health plan.
- H1N1 Impact: Monitor Q4 2009 claims data to assess the actual financial impact of the H1N1 flu on emergency room and outpatient utilization.
- Utah Capitation Risk: Review the performance of the Utah health plan under its new prepaid capitation model to ensure medical costs do not exceed fixed premiums.
- Tax Settlement Finality: Confirm the status of the Joint Committee on Taxation review regarding the $3.5 million tax benefit to rule out potential reversals.
- Claims Reserve Adequacy: Assess the "Incurred But Not Paid" (IBNP) reserve estimates, noting the company's sensitivity analysis indicates a 1% change in completion factors could impact net income by approximately $7.2 million.